Diplomat Pharmacy, Inc. Uncategorized Contracts & Agreements

Consent Letter Agreement with Brian Griffin (Filed With SEC on December 9, 2019)

Consent Letter Agreement with Dan Davison (Filed With SEC on December 9, 2019)

Form of Omnibus Amendment to Award Agreement (Filed With SEC on November 12, 2019)

Offer letter dated May 9, 2018 by and between Brian Griffin and the Company (Filed With SEC on August 7, 2018)

Sixth Amendment to Prime Vendor Agreement, effective October 24, 2017, by and among AmerisourceBergen Drug Corporation and each Company subsidiary named therein (Filed With SEC on March 1, 2018)

Commitment Letter by and among Diplomat Pharmacy, Inc., JPMorgan Chase Bank, N.A., and Capital One, National Association dated November 15, 2017 (Filed With SEC on November 16, 2017)

Fifth Amendment to Prime Vendor Agreement, effective August 3, 2017, by and among AmerisourceBergen Drug Corporation and the Company subsidiaries named therein (Filed With SEC on November 6, 2017)

Fourth Amendment to Prime Vendor Agreement, effective May 8, 2017, by and among AmerisourceBergen Drug Corporation and the Company subsidiaries named therein (Filed With SEC on November 6, 2017)

THIRD AMENDMENT TO PRIME VENDOR AGREEMENT (Filed With SEC on October 6, 2016)

General Electric Capital Corporation 2 Bethesda Metro Center Suite 600 Bethesda, MD 20814-5318 (Filed With SEC on February 29, 2016)

SECOND AMENDMENT TO PRIME VENDOR AGREEMENT (Filed With SEC on September 15, 2015)

First Amendment to Prime Vendor Agreement (Filed With SEC on August 19, 2014)

PRIME VENDOR AGREEMENT (Filed With SEC on August 19, 2014)